{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T03:47:07Z","timestamp":1776743227651,"version":"3.51.2"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.clml.2025.12.011","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T17:15:21Z","timestamp":1766164521000},"page":"e542-e552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Characteristics, Molecular Analysis and Survival Outcomes of Patients With Extramedullary Acute Myeloid Leukemia: A Retrospective Single-Center Study"],"prefix":"10.1016","volume":"26","author":[{"given":"Jingyu","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqiu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiwen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajuan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huibo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6772-5060","authenticated-orcid":false,"given":"Shengjin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.clml.2025.12.011_bib0001","doi-asserted-by":"crossref","first-page":"e813","DOI":"10.1016\/j.clml.2020.06.009","article-title":"Prognostic impact of extramedullary infiltration in pediatric low-risk acute myeloid leukemia: a retrospective single-center study over 10 years","volume":"20","author":"Hu","year":"2020","journal-title":"Clin Lymph Myelom Leuk"},{"issue":"1","key":"10.1016\/j.clml.2025.12.011_bib0002","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/MOP.0000000000000855","article-title":"Pediatric acute myeloid leukemia: updates on biology, risk stratification, and therapy","volume":"32","author":"Elgarten","year":"2020","journal-title":"Curr Opinion Pediatr"},{"issue":"5","key":"10.1016\/j.clml.2025.12.011_bib0003","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/2040620711410774","article-title":"Myeloid sarcoma: current approach and therapeutic options","volume":"2","author":"Avni","year":"2011","journal-title":"Therapeut Adv Hematol"},{"issue":"6","key":"10.1016\/j.clml.2025.12.011_bib0004","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.3324\/haematol.2019.223032","article-title":"The prevalence of extramedullary acute myeloid leukemia detected by 18FDG-PET\/CT: final results from the prospective PETAML trial","volume":"105","author":"St\u00f6lzel","year":"2020","journal-title":"Haematologica"},{"issue":"21","key":"10.1016\/j.clml.2025.12.011_bib0005","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1002\/cncr.34459","article-title":"Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations","volume":"128","author":"Ball","year":"2022","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.clml.2025.12.011_bib0006","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.leukres.2004.03.021","article-title":"Extramedullay acute myeloid leukemia infiltrates","volume":"28","author":"Tallman","year":"2004","journal-title":"Leuk Res"},{"issue":"1","key":"10.1016\/j.clml.2025.12.011_bib0007","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-022-01267-7","article-title":"Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations","volume":"15","author":"Eckardt","year":"2022","journal-title":"J Hematol Oncol"},{"issue":"2","key":"10.1016\/j.clml.2025.12.011_bib0008","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1200\/JCO.1997.15.2.466","article-title":"Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461","volume":"15","author":"Byrd","year":"1997","journal-title":"J Clin Oncol"},{"issue":"29","key":"10.1016\/j.clml.2025.12.011_bib0009","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1200\/JCO.2016.67.5892","article-title":"Extramedullary disease in adult acute myeloid leukemia is common but lacks independent significance: analysis of patients in ECOG-ACRIN Cancer Research Group trials, 1980-2008","volume":"34","author":"Ganzel","year":"2016","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.clml.2025.12.011_bib0010","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/cncr.23691","article-title":"Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia","volume":"113","author":"Tsimberidou","year":"2008","journal-title":"Cancer"},{"issue":"21","key":"10.1016\/j.clml.2025.12.011_bib0011","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood.V118.21.2003.2003","article-title":"Extramedullary leukemia and myeloid sarcoma in AML: results from a population-based registry study of 2261 patients","volume":"118","author":"Oestgaard","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.clml.2025.12.011_bib0012","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.clml.2025.12.011_bib0013","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.clml.2025.12.011_bib0014","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.clml.2025.12.011_bib0015","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/(SICI)1096-911X(199809)31:3<144::AID-MPO3>3.0.CO;2-B","article-title":"Granulocytic sarcoma in children with acute myeloblastic leukemia and t(8;21)","volume":"31","author":"Schwyzer","year":"1998","journal-title":"Med Pediatr Oncol"},{"issue":"4","key":"10.1016\/j.clml.2025.12.011_bib0016","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1200\/JCO.1993.11.4.690","article-title":"Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia","volume":"11","author":"Tallman","year":"1993","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.clml.2025.12.011_bib0017","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/j.1600-0560.2012.01981.x","article-title":"Trisomy 8 in myeloid leukemia cutis confirmed by fluorescence in situ hybridization analysis","volume":"39","author":"Shvartsbeyn","year":"2012","journal-title":"J Cutaneous Pathol"},{"issue":"5","key":"10.1016\/j.clml.2025.12.011_bib0018","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.clml.2017.02.027","article-title":"Myeloid Sarcoma: presentation, diagnosis, and treatment","volume":"17","author":"Almond","year":"2017","journal-title":"Clin Lymph Myelom Leuk"},{"issue":"1","key":"10.1016\/j.clml.2025.12.011_bib0019","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/10245332.2017.1333275","article-title":"Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: a single institution experience over 13 years","volume":"23","author":"Kaur","year":"2017","journal-title":"Hematology"},{"issue":"20","key":"10.1016\/j.clml.2025.12.011_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13206154","article-title":"Myeloid sarcoma: novel advances regarding molecular pathogenesis, presentation and therapeutic options","volume":"13","author":"Diamantidis","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.clml.2025.12.011_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.989366","article-title":"Incidence, clinical characteristics, and prognostic nomograms for patients with myeloid sarcoma: a SEER-based study","volume":"12","author":"Xing","year":"2022","journal-title":"Front Oncol"},{"issue":"16 Suppl","key":"10.1016\/j.clml.2025.12.011_bib0022","doi-asserted-by":"crossref","first-page":"6583","DOI":"10.1200\/JCO.2024.42.16_suppl.6583","article-title":"Meta-analysis of mutational site-specificity and concordance\/discordance characteristics of myeloid sarcoma","volume":"42","author":"Aguilar","year":"2024","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clml.2025.12.011_bib0023","first-page":"378","article-title":"Outcome of adult acute myeloid leukemia patients with extramedullary disease and treatment with venetoclax \/hypomethylating agents","volume":"110","author":"Kayser","year":"2025","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.clml.2025.12.011_bib0024","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/s41375-024-02337-0","article-title":"Clinical and molecular characteristics of extramedullary acute myeloid leukemias","volume":"38","author":"Kewan","year":"2024","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.clml.2025.12.011_bib0025","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-016-0337-3","article-title":"DNMT3A mutation leads to leukemic extramedullary infiltration mediated by TWIST1","volume":"9","author":"Xu","year":"2016","journal-title":"J Hematol Oncol"},{"issue":"17","key":"10.1016\/j.clml.2025.12.011_bib0026","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1182\/bloodadvances.2021004631","article-title":"Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia","volume":"5","author":"Stasik","year":"2021","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.clml.2025.12.011_bib0027","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1182\/bloodadvances.2021006242","article-title":"Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemia","volume":"6","author":"Fobare","year":"2022","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.clml.2025.12.011_bib0028","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/his.13864","article-title":"Clinicopathological and molecular characteristics of extramedullary acute myeloid leukaemia","volume":"75","author":"Ullman","year":"2019","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.clml.2025.12.011_bib0029","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.blre.2016.04.001","article-title":"Extramedullary acute myelogenous leukemia","volume":"30","author":"Solh","year":"2016","journal-title":"Blood Rev"},{"issue":"4","key":"10.1016\/j.clml.2025.12.011_bib0030","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/cyto.b.22219","article-title":"Myeloid sarcoma or mixed phenotype acute leukemia? Multiparametric flow cytometry to the rescue in an unusual diagnostic dilemma","volume":"108","author":"Srinivasan","year":"2025","journal-title":"Cytometry Part B: Clin Cytomet"},{"key":"10.1016\/j.clml.2025.12.011_bib0031","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.semcancer.2013.08.011","article-title":"The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: insight into disease biology and new targeted therapies","volume":"24","author":"Burger","year":"2014","journal-title":"Sem Can Biol"},{"issue":"23","key":"10.1016\/j.clml.2025.12.011_bib0032","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.clml.2025.12.011_bib0033","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/sj.leu.2404491","article-title":"Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients","volume":"21","author":"Pileri","year":"2006","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.clml.2025.12.011_bib0034","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41409-021-01250-9","article-title":"Effect of extramedullary disease on allogeneic hematopoietic cell transplantation for pediatric acute myeloid leukemia: a nationwide retrospective study","volume":"56","author":"Sakaguchi","year":"2021","journal-title":"Bone Marrow Transplantat"},{"key":"10.1016\/j.clml.2025.12.011_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.amsu.2021.102894","article-title":"Extramedullary acute myeloid leukemia (eAML): retrospective single center cohort study on clinico-pathological, molecular analysis and survival outcomes","volume":"72","author":"Halahleh","year":"2021","journal-title":"Ann Med Surg"},{"issue":"10","key":"10.1016\/j.clml.2025.12.011_bib0036","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/00043426-200310000-00004","article-title":"Extramedullary leukemia in children with newly diagnosed acute myeloid leukemia: a report from the Children's Cancer Group","volume":"25","author":"Dusenbery","year":"2003","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S215226502504306X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S215226502504306X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T03:17:55Z","timestamp":1776741475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S215226502504306X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S215226502504306X"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2025.12.011","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Characteristics, Molecular Analysis and Survival Outcomes of Patients With Extramedullary Acute Myeloid Leukemia: A Retrospective Single-Center Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2025.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}